Page 7 - Extracts Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article
Share this article
SANDUSKY, Ohio, Dec. 18, 2020 /PRNewswire/ PAO Group, Inc. (USOTC: PAOG) today announced the company expects to generate its first revenue next year in 2021 from its Cannabidiol (CBD) extraction technology, RespRx, acquired in July of this year, 2020.
Yesterday, PAOG announced an engagement with the Puerto Rico Consortium for Clinical Investigation (PRCCI) to assist PAOG with developing its proprietary CBD extract into a nutraceutical product to provide care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD).
PAOG, through its engagement with PRCCI expects to rapidly produce its CBD COPD Nutraceutical product and establish sales. Grand View Research forecasts the CBD Nutraceutical marketplace reaching a value of $12.7 billion by 2025. ....

United States , Puerto Rico , Jim Diprima , Puration Inc , Puerto Rico Consortium For Clinical Investigation , View Research , Alkame Holdings Inc , Securities Exchange , Extracts Inc , Group Inc , Puerto Rico Consortium , Clinical Investigation , Chronic Obstructive Pulmonary Disorder , Grand View Research , Alkame Holdings , Looking Statements , Securities Act , Securities Exchange Act , ஒன்றுபட்டது மாநிலங்களில் , ப்வெர்டோ ரிக்கோ , ஜிம் டிப்ரிமா , ப்வெர்டோ ரிக்கோ கூட்டமைப்பு க்கு மருத்துவ விசாரணை , பார்வை ஆராய்ச்சி , பத்திரங்கள் பரிமாற்றம் , சாறுகள் இன்க் , குழு இன்க் ,